HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protection of the blood-brain barrier by pentosan against amyloid-β-induced toxicity.

Abstract
Endothelial cells of brain capillaries forming the blood-brain barrier play an important role in the pathogenesis and therapy of Alzheimer's disease. Amyloid-β (Aβ) peptides are key pathological elements in the development of the disease. A blood-brain barrier model, based on primary rat brain endothelial cells was used in which the barrier properties were induced by glial cells. The effects of amyloid peptides have been tested on cell viability and barrier functions. Aβ showed toxic effects on primary rat brain endothelial cells measured by MTT dye conversion and the lactate dehydrogenase release. Morphologically cytoplasmic vacuolization, disruption of the structure of cytoplasmic organelles and tight junctions could be observed in brain endothelial cells. Treatment with Aβ1-42 decreased the electrical resistance, and increased the permeability of brain endothelial cell monolayers for both fluorescein and albumin. Serum amyloid P component which stabilizes Aβ fibrils in cortical amyloid plaques and cerebrovascular amyloid deposits significantly potentiated the barrier-weakening effect of Aβ1-42. Sulfated polysaccharide pentosan could decrease the toxic effects of Aβ peptides in brain endothelial cells. It could also significantly protect the barrier integrity of monolayers from damaging actions of peptides. Pentosan modified the size, and significantly decreased the number of amyloid aggregates demonstrated by atomic force microscopy. The present data further support the toxic effects of amyloid peptides on brain endothelial cells, and can contribute to the development of molecules protecting the blood-brain barrier in Alzheimer's disease.
AuthorsMária A Deli, Szilvia Veszelka, Boglárka Csiszár, Andrea Tóth, Agnes Kittel, Mária Csete, Aron Sipos, Anikó Szalai, Lívia Fülöp, Botond Penke, Csongor S Abrahám, Masami Niwa
JournalJournal of Alzheimer's disease : JAD (J Alzheimers Dis) Vol. 22 Issue 3 Pg. 777-94 ( 2010) ISSN: 1875-8908 [Electronic] Netherlands
PMID20847411 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amyloid beta-Peptides
  • Neuroprotective Agents
  • Peptide Fragments
  • amyloid beta-protein (1-40)
  • amyloid beta-protein (1-42)
  • Pentosan Sulfuric Polyester
Topics
  • Amyloid beta-Peptides (antagonists & inhibitors, toxicity)
  • Animals
  • Blood-Brain Barrier (drug effects, physiology, ultrastructure)
  • Cells, Cultured
  • Neuroprotective Agents (pharmacology)
  • Pentosan Sulfuric Polyester (pharmacology)
  • Peptide Fragments (antagonists & inhibitors, toxicity)
  • Rats

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: